Tags

Type your tag names separated by a space and hit enter

Overview of Parkinson's disease.
Pharmacotherapy. 2007 Dec; 27(12 Pt 2):155S-160S.P

Abstract

This overview of Parkinson's disease is designed to serve as a background to the discussion elsewhere in this supplement on the pharmacotherapy used in its management. Parkinson's disease is a common progressive neurodegenerative condition associated with significant disability and negative impact on quality of life. Although the cause of Parkinson's disease is unknown, the pathologic manifestation involves the loss or dysfunction of dopaminergic neurons in the substantia nigra pars compacta. Characteristic clinical manifestations include difficulty with coordinated movement such as asymmetric resting tremor, rigidity, and bradykinesia. These symptoms and their response to levodopa constitute the basis for a clinical diagnosis of Parkinson's disease. Postural instability and gait abnormalities occur in more advanced disease. Although there is no cure for Parkinson's disease, a number of pharmacologic treatments are available for managing the motor and nonmotor symptoms. Research is under way to assess the disease-modifying ability of both standard and newer treatments.

Authors+Show Affiliations

Division of Movement Disorders, Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. mlew@surgery.usc.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18041935

Citation

Lew, Mark. "Overview of Parkinson's Disease." Pharmacotherapy, vol. 27, no. 12 Pt 2, 2007, 155S-160S.
Lew M. Overview of Parkinson's disease. Pharmacotherapy. 2007;27(12 Pt 2):155S-160S.
Lew, M. (2007). Overview of Parkinson's disease. Pharmacotherapy, 27(12 Pt 2), 155S-160S.
Lew M. Overview of Parkinson's Disease. Pharmacotherapy. 2007;27(12 Pt 2):155S-160S. PubMed PMID: 18041935.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Overview of Parkinson's disease. A1 - Lew,Mark, PY - 2007/11/29/pubmed PY - 2008/2/27/medline PY - 2007/11/29/entrez SP - 155S EP - 160S JF - Pharmacotherapy JO - Pharmacotherapy VL - 27 IS - 12 Pt 2 N2 - This overview of Parkinson's disease is designed to serve as a background to the discussion elsewhere in this supplement on the pharmacotherapy used in its management. Parkinson's disease is a common progressive neurodegenerative condition associated with significant disability and negative impact on quality of life. Although the cause of Parkinson's disease is unknown, the pathologic manifestation involves the loss or dysfunction of dopaminergic neurons in the substantia nigra pars compacta. Characteristic clinical manifestations include difficulty with coordinated movement such as asymmetric resting tremor, rigidity, and bradykinesia. These symptoms and their response to levodopa constitute the basis for a clinical diagnosis of Parkinson's disease. Postural instability and gait abnormalities occur in more advanced disease. Although there is no cure for Parkinson's disease, a number of pharmacologic treatments are available for managing the motor and nonmotor symptoms. Research is under way to assess the disease-modifying ability of both standard and newer treatments. SN - 0277-0008 UR - https://www.unboundmedicine.com/medline/citation/18041935/Overview_of_Parkinson's_disease_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.